Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of aclerastide for non-healing diabetic foot ulcers
2015-002196-15Phase 3Terminated
- Sponsor
- Derma Sciences
- Start
- May 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Aclerastide 0.03% + standard of care, Vehicle + standard of care and Standard of care (3 arms). Primary endpoint: Primary efficacy analysis. Started May 2015; status: terminated.
02
Drugs
aclerastide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2015-002196-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002196-15.